336 related articles for article (PubMed ID: 27845275)
21. β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models.
Israel LL; Sun T; Braubach O; Cox A; Shatalova ES; Rashid HM; Galstyan A; Grodzinski Z; Song XY; Chepurna O; Ljubimov VA; Chiechi A; Sharma S; Phebus C; Wang Y; Ljubimova JY; Black KL; Holler E
J Control Release; 2023 Sep; 361():636-658. PubMed ID: 37544515
[TBL] [Abstract][Full Text] [Related]
22. GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.
Huang M; Hu M; Song Q; Song H; Huang J; Gu X; Wang X; Chen J; Kang T; Feng X; Jiang D; Zheng G; Chen H; Gao X
ACS Nano; 2015 Nov; 9(11):10801-16. PubMed ID: 26440073
[TBL] [Abstract][Full Text] [Related]
23. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
24. Blood-brain barrier penetration of an Aβ-targeted, arginine-rich, d-enantiomeric peptide.
Jiang N; Frenzel D; Schartmann E; van Groen T; Kadish I; Shah NJ; Langen KJ; Willbold D; Willuweit A
Biochim Biophys Acta; 2016 Nov; 1858(11):2717-2724. PubMed ID: 27423267
[TBL] [Abstract][Full Text] [Related]
25. Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model.
Mi X; Du H; Guo X; Wu Y; Shen L; Luo Y; Wang D; Su Q; Xiang R; Yue S; Wu S; Gong J; Yang Z; Zhang Y; Tan X
Acta Biomater; 2022 Mar; 141():388-397. PubMed ID: 35045359
[TBL] [Abstract][Full Text] [Related]
26. A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice.
Guo Q; Xu S; Yang P; Wang P; Lu S; Sheng D; Qian K; Cao J; Lu W; Zhang Q
J Control Release; 2020 Apr; 320():347-362. PubMed ID: 31978446
[TBL] [Abstract][Full Text] [Related]
27. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
[TBL] [Abstract][Full Text] [Related]
28. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
29. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L
J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771
[TBL] [Abstract][Full Text] [Related]
30. Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.
Spencer B; Trinh I; Rockenstein E; Mante M; Florio J; Adame A; El-Agnaf OMA; Kim C; Masliah E; Rissman RA
Neurobiol Dis; 2019 Jul; 127():163-177. PubMed ID: 30849508
[TBL] [Abstract][Full Text] [Related]
31. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
Alvarez-Erviti L; Seow Y; Yin H; Betts C; Lakhal S; Wood MJ
Nat Biotechnol; 2011 Apr; 29(4):341-5. PubMed ID: 21423189
[TBL] [Abstract][Full Text] [Related]
32. Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.
André S; Ansciaux E; Saidi E; Larbanoix L; Stanicki D; Nonclercq D; Vander Elst L; Laurent S; Muller RN; Burtea C
J Alzheimers Dis; 2017; 60(4):1547-1565. PubMed ID: 29036827
[TBL] [Abstract][Full Text] [Related]
33. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
[TBL] [Abstract][Full Text] [Related]
35. Gene Therapy Strategies for Alzheimer's Disease: An Overview.
Alves S; Fol R; Cartier N
Hum Gene Ther; 2016 Feb; 27(2):100-7. PubMed ID: 26838997
[TBL] [Abstract][Full Text] [Related]
36. Structural contributions of blocked or grafted poly(2-dimethylaminoethyl methacrylate) on PEGylated polycaprolactone nanoparticles in siRNA delivery.
Lin D; Huang Y; Jiang Q; Zhang W; Yue X; Guo S; Xiao P; Du Q; Xing J; Deng L; Liang Z; Dong A
Biomaterials; 2011 Nov; 32(33):8730-42. PubMed ID: 21885115
[TBL] [Abstract][Full Text] [Related]
37. Scanning ultrasound in the absence of blood-brain barrier opening is not sufficient to clear β-amyloid plaques in the APP23 mouse model of Alzheimer's disease.
Leinenga G; Koh WK; Götz J
Brain Res Bull; 2019 Nov; 153():8-14. PubMed ID: 31400496
[TBL] [Abstract][Full Text] [Related]
38. Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer's disease.
Jung SJ; Park SH; Lee EJ; Park JH; Kong YB; Rho JK; Hur MG; Yang SD; Park YD
Arch Pharm Res; 2015 Nov; 38(11):1992-8. PubMed ID: 26012373
[TBL] [Abstract][Full Text] [Related]
39. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis.
D'Andrea MR; Nagele RG
Biotech Histochem; 2010 Apr; 85(2):133-47. PubMed ID: 20121465
[TBL] [Abstract][Full Text] [Related]
40. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
